Andrea Harriott, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 9 | 2022 | 1411 | 2.350 |
Why?
|
| Cortical Spreading Depression | 5 | 2020 | 273 | 1.630 |
Why?
|
| Neurons, Afferent | 3 | 2012 | 517 | 0.930 |
Why?
|
| Headache Disorders | 2 | 2022 | 128 | 0.920 |
Why?
|
| Cluster Headache | 1 | 2022 | 44 | 0.910 |
Why?
|
| Facial Pain | 2 | 2015 | 124 | 0.830 |
Why?
|
| Headache | 5 | 2022 | 1109 | 0.780 |
Why?
|
| Dura Mater | 3 | 2012 | 294 | 0.770 |
Why?
|
| Brain Ischemia | 4 | 2020 | 3260 | 0.750 |
Why?
|
| Hyperalgesia | 1 | 2020 | 492 | 0.600 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2016 | 36 | 0.580 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2015 | 14 | 0.570 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2015 | 59 | 0.530 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1905 | 0.480 |
Why?
|
| Amnesia | 1 | 2015 | 241 | 0.470 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 45 | 0.460 |
Why?
|
| Sumatriptan | 1 | 2012 | 63 | 0.460 |
Why?
|
| Models, Animal | 1 | 2019 | 2221 | 0.460 |
Why?
|
| Skull Base | 1 | 2015 | 285 | 0.450 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2020 | 1080 | 0.430 |
Why?
|
| Visual Cortex | 2 | 2020 | 1137 | 0.420 |
Why?
|
| Auditory Cortex | 1 | 2014 | 335 | 0.410 |
Why?
|
| Stroke | 3 | 2019 | 9256 | 0.400 |
Why?
|
| Cysts | 1 | 2015 | 630 | 0.400 |
Why?
|
| Masseter Muscle | 2 | 2006 | 37 | 0.370 |
Why?
|
| Receptor, Serotonin, 5-HT1D | 1 | 2008 | 8 | 0.360 |
Why?
|
| Circle of Willis | 1 | 2008 | 72 | 0.350 |
Why?
|
| Tryptamines | 1 | 2008 | 86 | 0.340 |
Why?
|
| Calcium Channels | 1 | 2012 | 657 | 0.340 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 194 | 0.320 |
Why?
|
| Anxiety | 1 | 2020 | 3887 | 0.300 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5703 | 0.280 |
Why?
|
| Nerve Fibers | 1 | 2008 | 713 | 0.260 |
Why?
|
| Ion Channels | 1 | 2009 | 1086 | 0.260 |
Why?
|
| Action Potentials | 2 | 2009 | 1788 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18375 | 0.250 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 2100 | 0.240 |
Why?
|
| Neuralgia | 1 | 2009 | 514 | 0.240 |
Why?
|
| Trigeminal Ganglion | 3 | 2009 | 189 | 0.240 |
Why?
|
| Patch-Clamp Techniques | 3 | 2012 | 985 | 0.230 |
Why?
|
| Depression | 1 | 2020 | 7202 | 0.210 |
Why?
|
| Trigeminal Nerve | 1 | 2022 | 260 | 0.200 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 1948 | 0.190 |
Why?
|
| African Americans | 1 | 2015 | 5118 | 0.190 |
Why?
|
| Sensory Thresholds | 2 | 2014 | 400 | 0.190 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 224 | 0.180 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 2018 | 47 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2012 | 8593 | 0.170 |
Why?
|
| Afferent Pathways | 2 | 2009 | 316 | 0.160 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2017 | 44 | 0.160 |
Why?
|
| Migraine with Aura | 1 | 2019 | 173 | 0.160 |
Why?
|
| Headache Disorders, Secondary | 1 | 2016 | 32 | 0.150 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 137 | 0.150 |
Why?
|
| Research Personnel | 1 | 2020 | 513 | 0.140 |
Why?
|
| Electrical Synapses | 1 | 2014 | 20 | 0.140 |
Why?
|
| Inflammation | 3 | 2019 | 10019 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2018 | 252 | 0.140 |
Why?
|
| Cerebral Infarction | 1 | 2020 | 1039 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2020 | 2328 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4592 | 0.130 |
Why?
|
| Facial Muscles | 1 | 2015 | 160 | 0.130 |
Why?
|
| Animals | 13 | 2020 | 170486 | 0.130 |
Why?
|
| Photophobia | 1 | 2014 | 71 | 0.130 |
Why?
|
| Career Choice | 1 | 2020 | 743 | 0.130 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 9927 | 0.120 |
Why?
|
| Women's Health | 1 | 2022 | 1898 | 0.120 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2013 | 66 | 0.120 |
Why?
|
| Rats | 5 | 2012 | 25094 | 0.120 |
Why?
|
| Noise | 1 | 2014 | 267 | 0.110 |
Why?
|
| Neurology | 1 | 2020 | 732 | 0.110 |
Why?
|
| Electric Stimulation | 2 | 2009 | 1775 | 0.110 |
Why?
|
| Light | 2 | 2018 | 1418 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 532 | 0.110 |
Why?
|
| Humans | 20 | 2022 | 708843 | 0.110 |
Why?
|
| Essential Tremor | 1 | 2013 | 122 | 0.110 |
Why?
|
| Pain Threshold | 1 | 2014 | 596 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2748 | 0.090 |
Why?
|
| Temporal Muscle | 1 | 2009 | 28 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 2017 | 1412 | 0.090 |
Why?
|
| Brain Stem | 1 | 2014 | 848 | 0.090 |
Why?
|
| Bradykinin | 1 | 2009 | 223 | 0.090 |
Why?
|
| Superior Cervical Ganglion | 1 | 2008 | 34 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2503 | 0.090 |
Why?
|
| Biophysics | 1 | 2009 | 394 | 0.080 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2008 | 158 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2008 | 375 | 0.080 |
Why?
|
| Female | 13 | 2022 | 375205 | 0.080 |
Why?
|
| Pain | 1 | 2022 | 4636 | 0.080 |
Why?
|
| Histamine | 1 | 2009 | 519 | 0.080 |
Why?
|
| Exons | 1 | 2013 | 2472 | 0.080 |
Why?
|
| Calcitonin | 1 | 2008 | 352 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2009 | 604 | 0.080 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 156 | 0.070 |
Why?
|
| 4-Aminopyridine | 1 | 2006 | 85 | 0.070 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 177 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2006 | 481 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2020 | 3266 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 919 | 0.070 |
Why?
|
| Male | 12 | 2022 | 349524 | 0.060 |
Why?
|
| Trigeminal Nuclei | 1 | 2003 | 44 | 0.060 |
Why?
|
| Critical Care | 1 | 2016 | 2473 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2008 | 1188 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2008 | 2064 | 0.060 |
Why?
|
| Amino Acids | 1 | 2009 | 1752 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2945 | 0.060 |
Why?
|
| Pregnancy | 1 | 2022 | 26832 | 0.050 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 63 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 589 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2014 | 3954 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2008 | 5456 | 0.050 |
Why?
|
| Neurons | 1 | 2019 | 9385 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 13274 | 0.050 |
Why?
|
| Middle Aged | 5 | 2018 | 213752 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2009 | 3510 | 0.040 |
Why?
|
| Maze Learning | 1 | 2020 | 499 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 34151 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 253 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17218 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2013 | 6666 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 22989 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6530 | 0.040 |
Why?
|
| Movement | 1 | 2003 | 1459 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58184 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 71483 | 0.030 |
Why?
|
| Adult | 4 | 2017 | 211041 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2009 | 20170 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2020 | 628 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 55940 | 0.030 |
Why?
|
| Mice | 3 | 2020 | 80876 | 0.020 |
Why?
|
| Aged | 3 | 2018 | 161488 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 69553 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2641 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 23950 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6766 | 0.020 |
Why?
|
| Jaw | 1 | 2003 | 94 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21194 | 0.010 |
Why?
|
| Mutation | 2 | 2018 | 29262 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 11594 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11253 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 61932 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 12447 | 0.000 |
Why?
|